Keywords
How to Cite
Abstract
The therapy of Aquapheresis has been studied as a therapeutic tool for patients with volume overload refractory to treatment with ASA diuretics, whose main objective is to mitigate the clinical impact of the same in patients with decompensated heart failure and cardiorenal syndrome, recognizing positive cumulative balances in critically ill patients as a factor regardless of mortality. A search was made in the main scientific databases for review articles, and studies that included the Acuapheresis strategy. Bibliographic references were found in databases from 2005 to 2017. Aquapheresis therapy is a patented ultrafiltration therapy aimed at improving refractory overload in patients with congestive heart failure. There are gaps in knowledge regarding cost-effectiveness therapy, real adverse adverse event relationships attributable to it and candidates will benefit, and we believe that more quality studies are required to reach solid conclusions. So far there is no compelling evidence to support Aquapheresis therapy to implement its routine and routine use of the ICU.
References
Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract. 2012;120(4):c179-84. Disponible en: https://doi.org/10.1159/000339789
Alobaidi R, Basu RK, Goldstaein SL, Bagshaw SM. Sepsis-associated acute kidney injury. Semin Nephrol. 2015;35(1):2-11. Disponible en: https://doi.org/10.1016/j.semnephrol.2015.01.002
Martensson J, Bellomo R. Sepsis-Induced Acute Kidney Injury. Crit Care Clin. 2015;31(4):649-60. Disponible en:https://doi.org/10.1016/j.ccc.2015.06.003
Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816-28. Disponible en: https://doi.org/10.1007/s00134-017-4755-7
Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209-16. Disponible en: https://doi.org/10.1016/j.ahj.2004.08.005
Ronco C. Cardiorenal and renocardiac syndromes: clinical disorders in search of a systematic definition. Int J Artif Organs. 2008:31(1):1-2. Disponible en: https://doi.org/10.1177/039139880803100101
Ronco C, Di Lullo L. Cardiorenal Syndrome. Heart Failure Clin. 2014;10(2):251-80. Disponible en: https://doi.org 10.1016/j.hfc.2013.12.003.
Ronco C, Bellasi A, Di Lullo L. Cardiorenal Syndrome: An Overview. Adv Chronic Kidney Dis. 2018;25(5):382-90. Disponible en: https://doi.org/10.1053/j.ackd.2018.08.004
Di Lullo L, Reeves PB, Bellasi A, Ronco C. Cardiorenal Syndrome in Acute Kidney Injury. Semin Nephrol. 2019;39(1): 31-40. Disponible en: https://doi.org/10.1016/j.semnephrol. 2018.10.003
Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. Eur Heart J. 2010;31(6):703-11. Disponible en: https://doi.org/10.1093/eurheartj/ ehp507
Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies. A Scientific Statement from the American Heart Association. Circulation. 2019; 139(16):e840-78. Disponible en: https://doi.org/10.1161/CIR.0000000000000664
Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589-96.
Disponible en: https://doi.org/10.1016/ j.jacc.2008.05.068
Winton FR. The influence of venous pressure on the isolated mammalian kidney. J Physiol. 1931;72(1):49-61. Disponible en: https://doi.org/10.1113/jphysiol.1931.sp002761
Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007;9(9):872-8. Disponible en: https://doi.org/10.1016/j.ejheart.2007.05.010
Dantzker DR. Cuidados Intensivos cardiopulmonares. 3ra ed. México D.F.: McGraw-Hill; 2000.
Haase M, Müller C, Damman K, Murray PT, Kellum JA, Ronco C, et al. Pathogenesis of cardiorenal syndrome type 1 in acute de compensated heart failure: workgroup statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:99-116. Disponible en: https://doi.org/10.1159/000349969
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393-408. Disponible en: https://doi.org/10.1172/JCI46122
Virzi GM, Zhang J, Nalesso F, Ronco C, McCullough PA. The role of dendritic and endothelial cells in cardiorenal syndrome. Cardiorenal Med. 2018;8(2):92-104 Disponible en: https://doi.org/10.1159/000485937
Claure-Del Granado, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrology. 2016;17(1):109. Disponible en: https://doi.org/10.1186/s12882-016-0323-6.
Shen Y, Huang X, Zhang W. Association between fluid intake and mortality in critically ill patients with negative fluid balance: a retrospective cohort study. Critical Care. 2017;21(1):104. Disponible en: https://doi.org/10.1186/s13054-017-1692-3.
Acheampong A, Vincent JL. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care. 2015;19:251. Disponible en: https://doi.org/10.1186/s13054-015-0970-1
Brotfain E, Koyfman L, Toledano R, Borer A, Fucs L, Galante O, et al. Positive fluid balance as a major predictor of clinical outcome of patients with sepsis/septic shock after discharge. Am J Emerg Med. 2016;34(11):2122-6. Disponible en: https://doi.org/10.1016/ j.ajem.2016.07.058
Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259-65. Disponible en: https://doi.org/10.1097/ CCM.0b013e3181feeb15
Wang N, Jiang L, Zhu B, Wen Y, Xi XM. Fluid balance and mortality in critically ill patients with acute kidney injury: a multicenter prospective epidemiological study. Crit Care. 2015;19:371. Disponible en: https://doi.org/10.1186/s13054-015-1085-4
Hernández AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, et al. Relationship between early physician follow- up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010; 303(17):1716-22. Disponible en: https://doi.org/10.1001/jama.2010.533
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129-2200. Disponible en: https://doi.org/10.1093/eurheartj/ehw128
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364(9):797-805. Disponible en: https://doi.org/10.1056/NEJMoa1005419
Ter Maaten JM, Valente MA, Damman K, Hillege HL, Navis G, Voors AA. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy. Nat Rev Cardiol. 2015;12(3):184-92. Disponible en: https://doi.org/10.1038/nrcardio.2014.215
Voors AA, Davinson BA, Teerlink JR, Felker GM, Cotter G, Filippatos G, et al. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF. Eur J Heart Fail. 2014;16(11): 1230-40. Disponible en: https://doi.org/10.1002/ejhf.170
Constanzo MR, Ronco C, Abraham WT, Agostoni P, Barasch J, Fonarow GC, et al. Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research. J Am Coll Cardiol. 2017;69(19):2428-45. Disponible en: https://doi.org/10.1016/j.jacc.2017.03.528
Macedo E, Mehta RL. Continuous Dialysis Therapies: Core Curriculum 2016. Am J Kidney Dis. 2016;645-57. Disponible en: https://doi.org/10.1053/j.ajkd.2016.03.427
Patarroyo M, Wehbe E, Hanna M, Taylor DO, Starling RC, Demirjian S, et al. Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients with Advanced Decompensated Heart Failure. J Am Coll Cardiol. 2012; 60(19):1906-12. Disponible en: https://doi.org/10.1016/j.jacc.2012.08.957
Aquadex FlexFlow® System. Baxter; [citado 2019 nov 21]. Disponible en: https://www.chfsolutions.com aquadex-flexflow-system.
Constanzo MR, Saltzberg M, O’Sullivan J, Sobotka P. Early Ultrafiltration in Patients with Decompensated Heart Failure and Diuretic Resistance. J Am Coll Cardiol. 2005;46(11):2047-51. Disponible en: https://doi.org/10.1016/j.jacc.2005.05.099
Bart BA, Boyle A, Bank AJ, Anand I, Olivari MT, Kraemer M, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients with Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol. 2005;46(11):2043-6. Disponible en: https://doi.org/10.1016/j.jacc.2005.05.098
Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49(6):675-83. Disponible en: https://doi.org/10.1016/ j.jacc.2006.07.073
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367(24):2296-304. Disponible en: https://doi.org/10.1056/NEJMoa1210357
Wen H, Zhang Y, Zhu J, Lan Y, Yang H. Ultrafiltration versus Intravenous Diuretic Therapy to Treat Acute Heart Failure: A Systematic Review. Am J Cardiovasc Drugs. 2013; 15(5):365-73. Disponible en: https://doi.org/10.1007/s40256-013-0034-3.
Barkoudah E, Kodali S, Okoroh J, Sethi R4, Hulten E5, Suemoto C, et al. Meta-analysis of Ultrafiltration versus Diuretics Treatment Option for Overload Volume Reduction in Patients with Acute Decompensated Heart Failure. Arq Bras Cardiol. 2015;104(5):417-25. Disponible en: https://doi.org/10.5935/abc.20140212.
Costanzo MR, Negoianu D, Jaski BE, Bart BA, Heywood JT, Anand IS, et al. Aquapheresis versus intravenous diuretics and hospitalizations for heart failure. JACC Heart Fail. 2016;4(2):95-105. Disponible en: https://doi.org/10.1016/j.jchf.2015.08.005
Giglioli C, Landi D, Cecchi E, Chiostri M, Gensini GF, Valente S, et al. Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study. Eur J Heart Fail. 2011;13(3):337- 46. Disponible en: https://doi.org/10.1093/eurjhf/hfq207
Marenzi G, Muratori M, Cosentino ER, Rinaldi ER, Donghi V, Milazzo V, et al. Continuous ultrafiltration or congestive heart failure: the CUORE trial. J Card Fail. 2014;20(1):9-17. Disponible en: https://doi.org/10.1016/j.cardfail.2013.11.004
Constanzo MR, Fonarow GC, Rizzo JA. Ultrafiltration versus diuretics for the treatment of fluid overload in patients with heart failure: a hospital cost analysis. J Med Econ. 2019;22(6):577-83. Disponible en: https://doi.org/10.1080/13696998.2019.1584109
U.S. National Library of Medicine (NIH). CVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart Failure (Aquadex). NIH; 2014.
U.S. National Library of Medicine (NIH). Ultrafiltration Versus Medical Therapies In the Management of the Cardio Renal Syndrome (UF-CARE). NIH; 2018. https://clinicaltrials.gov
U.S. National Library of Medicine (NIH). PURE-HF: Peripheral Ultrafiltration for the Relief from Congestion in Heart Failure. NIH; 2019. https://clinicaltrials.gov